Singapore markets open in 5 hours 56 minutes
  • Straits Times Index

    3,166.27
    -55.25 (-1.72%)
     
  • S&P 500

    4,594.62
    -106.84 (-2.27%)
     
  • Dow

    34,899.34
    -905.06 (-2.53%)
     
  • Nasdaq

    15,491.66
    -353.54 (-2.23%)
     
  • BTC-USD

    54,156.35
    -787.27 (-1.43%)
     
  • CMC Crypto 200

    1,365.60
    -89.81 (-6.17%)
     
  • FTSE 100

    7,044.03
    -266.34 (-3.64%)
     
  • Gold

    1,792.30
    +8.00 (+0.45%)
     
  • Crude Oil

    68.17
    -10.22 (-13.04%)
     
  • 10-Yr Bond

    1.4820
    -0.1630 (-9.91%)
     
  • Nikkei

    28,751.62
    -747.68 (-2.53%)
     
  • Hang Seng

    24,080.52
    -659.68 (-2.67%)
     
  • FTSE Bursa Malaysia

    1,512.22
    -5.38 (-0.35%)
     
  • Jakarta Composite Index

    6,561.55
    -137.80 (-2.06%)
     
  • PSE Index

    7,278.44
    -90.83 (-1.23%)
     

Europe Gastro-Esophageal Reflux Disease Market and Competitive Landscape Report 2021-2026: Pipeline, Epidemiology, Valuations, Forecasts, Drug Sales, Drug Forecasts, and Market Shares - ResearchAndMarkets.com

·2-min read

DUBLIN, October 20, 2021--(BUSINESS WIRE)--The "Europe Gastro-Esophageal Reflux Disease Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.

Europe Gastro-Esophageal Reflux Disease Market and Competitive Landscape 2021, provides comprehensive insights into Gastro-Esophageal Reflux Disease pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares.

This research analyzes and forecasts Gastro-Esophageal Reflux Disease market size and drug sales. It also provides insights into Gastro-Esophageal Reflux Disease epidemiology and late-stage pipeline.

This research covers the following - Gastro-Esophageal Reflux Disease treatment options, Gastro-Esophageal Reflux Disease late-stage clinical trials pipeline, Gastro-Esophageal Reflux Disease prevalence by countries, Gastro-Esophageal Reflux Disease market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).

Research Scope:

  • Countries: Germany, France, Italy, Spain, UK, Europe

  • Gastro-Esophageal Reflux Disease pipeline: Find out drugs in clinical trials for the treatment of Gastro-Esophageal Reflux Disease by development phase 3, phase 2, by pharmacological class and company

  • Gastro-Esophageal Reflux Disease epidemiology: Find out the number of patients diagnosed (prevalence) with Gastro-Esophageal Reflux Disease by countries

  • Gastro-Esophageal Reflux Disease drugs: Identify key drugs marketed and prescribed for Gastro-Esophageal Reflux Disease in the US, including trade name, molecule name, and company

  • Gastro-Esophageal Reflux Disease drugs sales: Find out the sales value for Gastro-Esophageal Reflux Disease drugs by countries

  • Gastro-Esophageal Reflux Disease market valuations: Find out the market size for Gastro-Esophageal Reflux Disease drugs in 2020 by countries. Find out how the market advanced from 2018 and forecast to 2026

  • Gastro-Esophageal Reflux Disease drugs market share: Find out the market shares for key drugs by countries

Benefits of this Research:

  • Evaluate commercial market opportunities for Gastro-Esophageal Reflux Disease drugs

  • Synthesize insights for business development & licensing

  • Track market size, competitor drug sales, market shares in Gastro-Esophageal Reflux Disease market

  • Develop in-depth knowledge of competition and markets

  • Analyze Gastro-Esophageal Reflux Disease drug sales data to update your brand planning trackers

  • Develop tactics and strategies to take advantage of opportunities in the market

  • Track Market Events and Trends and analyze key events in Gastro-Esophageal Reflux Disease market

  • Develop forecast models, healthcare frameworks, or economic models

  • Answer key business questions; supports decision making in R&D to long term marketing strategies

For more information about this report visit https://www.researchandmarkets.com/r/fhy1k4

View source version on businesswire.com: https://www.businesswire.com/news/home/20211020005745/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting